NEWS: Leaders in Gastroenterology propose a rational for the non-invasive screening of Atrophic Gastritis using stomach-specific biomarkers.

A recent paper published by an international group of key opinion leaders in Gastroenterology proposes a guide for putting the Biohit GastroPanel blood test into clinical practice.  Biohit's GastroPanel is a screening test for selecting patients for gastroscopy, ruling out stomach disease and providing a risk assesment in patients with dyspepsia.

Biohit Healthcare in brief

Biohit is a globally operating biotechnology company that develops, manufactures and markets diagnostic tests and analysis systems. 

Our products are used by research and health care world wide.

• Established in 1988 by Professor Osmo Suovaniemi

• Business area: Diagnostics

• Headquartered in Finland, Helsinki.

• Subsidiary is located in  the UK

• Production plant ís located in Finland.

• Biohit's products are sold by many distributors around the world.

• Biohit Oyj's share (BIOBV) is quoted on NASDAQ OMX Helsinki since June1999, Small cap/Healthcare.